Londono Tobon, Amalia http://orcid.org/0000-0001-7527-3327
Flores, José M.
Taylor, Jerome H.
Johnson, Isaac
Landeros-Weisenberger, Angeli
Aboiralor, Okoduwa
Avila-Quintero, Victor J.
Bloch, Michael H.
Funding for this research was provided by:
American Psychiatric Association (None, None)
Article History
Received: 10 February 2020
Accepted: 4 November 2020
First Online: 12 January 2021
Change Date: 5 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40596-021-01435-w
Compliance with ethical standards
:
: A.LT. is supported by NIMH (5T32MH018268-34), the Ariella Ritvo grant. M.H.B. receives research support from Therapix Biosciences, Neurocrine Biosciences, Janssen Pharmaceuticals and Biohaven Pharmaceuticals, but received no support from these sources for the current manuscript. M.H.B. gratefully acknowledges additional research support from NIH. J.H.T is supported by the National Center for Advancing Translational Sciences at the NIH (KL2TR001879) and the Brain and Behavior Research Foundation. Mr. Johnson is supported by the Yale School of Medicine Medical Student Research Fellowship. Dr. Flores receives financial support for his research from NIH training grant T32MH018268. Dr. Landeros-Wisenberger, Dr. Avila-Quintero, Mr. Johnson, and Mr. Aboiralor report no financial relationships with commercial interests.